Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery

NCT ID: NCT03086304

Last Updated: 2019-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

610 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-28

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative intestinal obstruction (POI) is one of the most common complications in the gastrointestinal surgery. Compared with the conventional control group, transcutaneous acupoint electrical stimulation(TEAS) is possible to reduce the incidence of POI and accelerate the rapid recovery of the gastrointestinal tract.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be randomly assigned, in a 1:1 ratio, to receive TEAS or Blank treatment (acupoints selection are same with the experimental group, connect stimulator for patients, but not don't give stimulus). The randomization sequence will be computer-generated, and randomization will be performed in blocks and will be stratified according to participating center. TEAS will be performed in a series of time periods after operation. Time of first fart and food-taking ,time of have normal diet after the transplantation will be recorded. The participation of each patient is scheduled for 30 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Intestinal Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
Randomised Controlled Trial

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TEAS group

Choose several acupoints,give 2/10 hz dilatational wave stimulation.Complete the 30 minutes intervention after extubation and 1-3 days after surgery.Give a health education on the first postoperative day.

Group Type EXPERIMENTAL

transcutaneous acupoint electrical stimulation

Intervention Type DEVICE

Transcutaneous acupoint electrical stimulation is same to the traditional Chinese medicine acupuncture treatment,treat diseases by stimulate different acupuncture points.

no TEAS group

The choice of acupoints are same with TEAS group,tape over the electrode but don't give electroacupuncture stimulation,the others steps are same with TEAS group.

Group Type EXPERIMENTAL

no transcutaneous acupoint electrical stimulation

Intervention Type DEVICE

the choice of acupoints are same with TEAS group,tape over the electrode but don't give electroacupuncture stimulation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcutaneous acupoint electrical stimulation

Transcutaneous acupoint electrical stimulation is same to the traditional Chinese medicine acupuncture treatment,treat diseases by stimulate different acupuncture points.

Intervention Type DEVICE

no transcutaneous acupoint electrical stimulation

the choice of acupoints are same with TEAS group,tape over the electrode but don't give electroacupuncture stimulation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All the patients signed the informed consent before treatment;
* Age ≥ 18 years old,American society of Anesthesiologists(ASA)grade are between I and III;
* Plan to perform elective colon and rectal tumor resection under general anesthesia;
* not involved in other clinical studies;
* no cognitive impairment, mental disorders,communication disorders.

Exclusion Criteria

* Pregnancy, breast-feeding;
* The history of intestinal surgery;
* Test point skin injury, infection, allergies to tape;
* have undergone external enterostomy;
* Chief surgeon refuse to cooperate.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaanxi Provincial People's Hospital

OTHER

Sponsor Role collaborator

Xi'an Central Hospital

OTHER

Sponsor Role collaborator

Ankang Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Affiliated Hospital of Shaanxi University of traditional Chinese Medicine

UNKNOWN

Sponsor Role collaborator

Ankang Central Hospital

OTHER

Sponsor Role collaborator

Weinan Central Hospital

OTHER

Sponsor Role collaborator

Central Railway Group of Xi'an Central Hospital

UNKNOWN

Sponsor Role collaborator

Xi'an Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Yan'an University Affiliated Hospital

OTHER

Sponsor Role collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Qiang Wang, PHD

Role: STUDY_CHAIR

First Affiliated Hospital of Xian JiaotongUniversity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankang Central Hospital

Ankang, Shaanxi, China

Site Status

Ankang Hospital of Traditional Chinese Medicine

Ankang, Shaanxi, China

Site Status

Weinan Central Hospital

Weinan, Shaanxi, China

Site Status

Xi'an Central Hospital

Xi'an, Shaanxi, China

Site Status

Xi'an Hospital of traditional Chinese Medicine

Xi'an, Shaanxi, China

Site Status

Central Railway Group of Xi'an Central Hospital

Xi'an, Shaanxi, China

Site Status

First Affiliated Hospital of Xian JiaotongUniversity

Xi'an, Shaanxi, China

Site Status

Shaanxi Provincial People's Hospital

Xi'an, Shaanxi, China

Site Status

Affiliated Hospital of Shaanxi University of traditional Chinese Medicine

Xianyang, Shaanxi, China

Site Status

Affiliated Hospital of Yan'an University

Yan’an, Shaanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XJTU1AF-CRF-2016-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.